<table border="1" class="dataframe">
  <thead>
    <tr>
      <th></th>
      <th></th>
      <th colspan="5" halign="left">Grouped by Diabetes history</th>
    </tr>
    <tr>
      <th></th>
      <th></th>
      <th>Missing</th>
      <th>Overall</th>
      <th>No Prior Diabetes</th>
      <th>Prior Diabetes</th>
      <th>P-Value</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>n</th>
      <th></th>
      <td></td>
      <td>70393</td>
      <td>14606</td>
      <td>55787</td>
      <td></td>
    </tr>
    <tr>
      <th>Age, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>52.0 [45.0,57.0]</td>
      <td>47.0 [40.0,53.0]</td>
      <td>53.0 [47.0,57.0]</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">Sex, n (%)</th>
      <th>Female</th>
      <td></td>
      <td>42310 (60.1)</td>
      <td>11571 (79.2)</td>
      <td>30739 (55.1)</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>Male</th>
      <td></td>
      <td>28083 (39.9)</td>
      <td>3035 (20.8)</td>
      <td>25048 (44.9)</td>
      <td></td>
    </tr>
    <tr>
      <th rowspan="3" valign="top">First semaglutide - brand name, n (%)</th>
      <th>Ozempic</th>
      <td></td>
      <td>52774 (75.0)</td>
      <td>8143 (55.8)</td>
      <td>44631 (80.0)</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>RYBELSUS</th>
      <td></td>
      <td>12264 (17.4)</td>
      <td>2011 (13.8)</td>
      <td>10253 (18.4)</td>
      <td></td>
    </tr>
    <tr>
      <th>WEGOVY</th>
      <td></td>
      <td>5355 (7.6)</td>
      <td>4452 (30.5)</td>
      <td>903 (1.6)</td>
      <td></td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">First semaglutide - dosage form, n (%)</th>
      <th>INJECTION, SOLUTION</th>
      <td></td>
      <td>58129 (82.6)</td>
      <td>12595 (86.2)</td>
      <td>45534 (81.6)</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>TABLET</th>
      <td></td>
      <td>12264 (17.4)</td>
      <td>2011 (13.8)</td>
      <td>10253 (18.4)</td>
      <td></td>
    </tr>
    <tr>
      <th>First semaglutide - total payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>825.7 [771.1,1307.8]</td>
      <td>849.2 [796.3,1311.7]</td>
      <td>822.6 [765.7,1240.9]</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>First semaglutide - out-of-pocket payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>50.0 [25.0,100.0]</td>
      <td>55.8 [25.0,120.0]</td>
      <td>50.0 [25.0,100.0]</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>Average monthly total payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>1176.4 [707.8,1982.8]</td>
      <td>876.0 [523.4,1471.5]</td>
      <td>1265.0 [772.5,2113.4]</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>Average monthly out-of-pocket payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>146.5 [85.5,228.7]</td>
      <td>117.0 [63.8,193.2]</td>
      <td>154.3 [92.2,236.2]</td>
      <td>&lt;0.001</td>
    </tr>
  </tbody>
</table>